Ozempic (semaglutide) injection for Type 2 Diabetes

1 day ago
bookmarkBookmark

Key facts

Classified as: organization
live News:
  • Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
  • Wegovy and Ozempic top list of 15 drugs up for next price negotiations
  • Ozempic, Wegovy top list of Biden's price-negotiation drugs
  • Ozempic picked for Medicare price bargaining

Summary

Ozempic (semaglutide) injection for Type 2 Diabetes is a company. It is located in the United States. The company is part of the Health Care sector.

Business

Ozempic (semaglutide) injection for Type 2 Diabetes is one of the companies in the United States, companies in Health Care and 3,466,499 companies in our database.
  • Employees: get AI+ to see estimate
  • Revenues: get AI+ to see estimate

Stocks from Ozempic (semaglutide) injection for Type 2 Diabetes

Explore more on business

Talking Points:

  • Ozempic® (semaglutide) injection for Type 2 Diabetes
  • Ozempic® (semaglutide) injection is a once-weekly GLP-1 RA medicine that, along with diet and exercise, may help improve blood sugar in adults with type 2 diabetes. Read Important Safety Information, including Boxed Warning.
Learn more about talking points

In literature

There is no book written about Ozempic (semaglutide) injection for Type 2 Diabetes in the database

Related

Connected or similar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

This content can be used under the CC BY 4.0 license